Avestar Capital, LLC Jazz Pharmaceuticals PLC Transaction History

Avestar Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 09, 2019	SELL	$121.81 - $142.95 $10,475 - $12,293	-86 Closed	0 $0
Q4 2018 Jan 25, 2019	SELL	$115.94 - $166.74 $347 - $500	-3 Reduced 3.37%	86 $10,000
Q3 2018 Oct 23, 2018	SELL	$161.01 - $180.57 $1,127 - $1,263	-7 Reduced 7.29%	89 $14,000
Q2 2018 Aug 10, 2018	BUY	$146.33 - $183.18 $12,584 - $15,753	86 Added 860.0%	96 $15,000
Q1 2018 May 10, 2018	BUY	$135.59 - $157.16 $135 - $157	1 Added 11.11%	10 $1,000
Q4 2017 Feb 14, 2018	BUY	$131.06 - $150.39 $1,179 - $1,353	9	9 $1,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.76B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.